Carmichael Hill & Associates, Inc. Beyond Air, Inc. Transaction History
Carmichael Hill & Associates, Inc.
- $279 Million
- Q3 2024
A detailed history of Carmichael Hill & Associates, Inc. transactions in Beyond Air, Inc. stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 8,000 shares of XAIR stock, worth $11,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000
Previous 8,000
-0.0%
Holding current value
$11,200
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XAIR
# of Institutions
18Shares Held
1.79MCall Options Held
49.6KPut Options Held
0-
Black Rock Inc. New York, NY519KShares$726,5790.0% of portfolio
-
Lasry Marc New York, NY82KShares$114,7298.33% of portfolio
-
Kaye Capital Management El Segundo, CA26.2KShares$36,6800.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA17.8KShares$24,8650.0% of portfolio
-
Baldwin Brothers LLC15.4KShares$21,5600.0% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $41.8M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...